The investigational device exemption (IDE) allows initiation of a global pivotal study designed to assess the safety and efficacy of the ARCIM System®, an implantable neurostimulation technology ...
DALLAS, September 15, 2025 — Nearly half of U.S. adults — 122.4 million people — are living with high blood pressure (BP), a leading preventable risk factor for heart disease, stroke and premature ...
Intensive target less than 120 mm Hg cost-effective even in scenarios with high measurement error. HealthDay News — For patients 50 years or older at high ...
Blood pressure targets are not normally met in patients that are prescribed 3 or more antihypertensive medications. A study published in the Journal of the American Heart Association found that most ...
Participants with eGFR 45 mL/min/1.73 m2 had greater net benefits than those with eGFR ≥45 mL/min/1.73 m2. (HealthDay News) — Nearly all adults with chronic kidney disease (CKD) would benefit from a ...
More than one third of patients with coronary heart disease had blood pressure (BP) less than 120/70 mm Hg, which is below the target range recommended by current European guidelines. These patients ...
A discovery in rats challenges long-held beliefs about hypertension and points to the brain as a new treatment target The research, led by McGill University scientist Masha Prager-Khoutorsky in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results